Literature DB >> 6283349

Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

M R Bristow, R Ginsburg, W Minobe, R S Cubicciotti, W S Sageman, K Lurie, M E Billingham, D C Harrison, E B Stinson.   

Abstract

To identify the role of the myocardial beta-adrenergic pathway in congestive heart failure, we examined beta-adrenergic-receptor density, adenylate cyclase and creatine kinase activities, muscle contraction in vitro, and myocardial contractile protein levels in the left ventricles of failing and normally functioning hearts from cardiac-transplant recipients or prospective donors. Eleven failing left ventricles had a 50 to 56 per cent reduction in beta-receptor density, a 45 per cent reduction in maximal isoproterenol-mediated adenylate cyclase stimulation, and a 54 to 73 per cent reduction in maximal isoproterenol-stimulated muscle contraction, as compared with six normally functioning ventricles (P less than 0.05 for each comparison). In contrast, cytoplasmic creatine kinase activity, adenylate cyclase activities stimulated by fluoride ion and by histamine, histamine-stimulated muscle contraction, and levels of contractile protein were not different in the two groups (P less than 0.05). We conclude that in failing human hearts a decrease in beta-receptor density leads to subsensitivity of the beta-adrenergic pathway and decreased beta-agonist-stimulated muscle contraction. Regulation of beta-adrenergic receptors may be an important variable in cardiac failure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283349     DOI: 10.1056/NEJM198207223070401

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  478 in total

1.  Prediction of contractile reserve by cyclic variation of integrated backscatter of the myocardium in patients with chronic left ventricular dysfunction.

Authors:  T Muro; T Ota; H Watanabe; M Teragaki; K Takeuchi; J Yoshikawa
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 2.  Myocardial gene transfer.

Authors:  D C White; W J Koch
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

3.  Augmenting beta receptors in the heart: short-term gains offset by long-term pains?

Authors:  L E Limbird; D E Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

4.  Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.

Authors:  D C White; J A Hata; A S Shah; D D Glower; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 5.  Transcriptional regulation by cAMP in the heart.

Authors:  F U Müller; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

6.  Hibernating myocardium in post-ischaemic heart failure: pathophysiology, identification and revascularisation.

Authors:  D Pagano
Journal:  Ann R Coll Surg Engl       Date:  2000-07       Impact factor: 1.891

7.  Functional properties of the rat phosphatase 1alpha promoter.

Authors:  B Linck; P Boknik; J Knapp; K Kikuchi; H Lüss; F U Müller; K Nomoto; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

Review 8.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

9.  Alterations of cardiac beta-adrenoceptor mechanisms due to calcium depletion and repletion.

Authors:  Xi Wang; Jingwei Wang; Satoshi Takeda; Vijayan Elimban; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

10.  Type 1 phosphatase, a negative regulator of cardiac function.

Authors:  Andrew N Carr; Albrecht G Schmidt; Yoichi Suzuki; Federica del Monte; Yoji Sato; Carita Lanner; Kristine Breeden; Shao-Ling Jing; Patrick B Allen; Paul Greengard; Atsuko Yatani; Brian D Hoit; Ingrid L Grupp; Roger J Hajjar; Anna A DePaoli-Roach; Evangelia G Kranias
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.